120 related articles for article (PubMed ID: 38388217)
1. Risk factors of liver abscess and biloma formation after drug-eluting bead transarterial chemoembolization for unresectable intrahepatic cholangiocarcinoma.
Bian L; Yang J; Song Z
Arab J Gastroenterol; 2024 May; 25(2):176-181. PubMed ID: 38388217
[TBL] [Abstract][Full Text] [Related]
2. Liver abscess after drug-eluting bead chemoembolization in patients with metastatic hepatic tumors.
Ye T; Zhu P; Liu Z; Ren Q; Zheng C; Xia X
Br J Radiol; 2022 Jan; 95(1129):20211056. PubMed ID: 34762523
[TBL] [Abstract][Full Text] [Related]
3. Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.
Monier A; Guiu B; Duran R; Aho S; Bize P; Deltenre P; Dunet V; Denys A
Eur Radiol; 2017 Apr; 27(4):1431-1439. PubMed ID: 27436016
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy and safety of conventional transarterial chemoembolization and drug-eluting bead transarterial chemoembolization in unresectable intrahepatic cholangiocarcinoma: A multicenter retrospective cohort study.
Zhang Z; Jiang N; Yin X; Xu A; Hao Y; Li H; Yang W; Mu K
Eur J Radiol; 2024 Jul; 176():111541. PubMed ID: 38843693
[TBL] [Abstract][Full Text] [Related]
5. Conventional and drug-eluting beads transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis.
He M; Jiang N; Yin X; Xu A; Mu K
J Cancer Res Clin Oncol; 2023 Jan; 149(1):531-540. PubMed ID: 36402872
[TBL] [Abstract][Full Text] [Related]
6. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
[No Abstract] [Full Text] [Related]
7. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
Kuhlmann JB; Euringer W; Spangenberg HC; Breidert M; Blum HE; Harder J; Fischer R
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):437-43. PubMed ID: 22261548
[TBL] [Abstract][Full Text] [Related]
8. Liver abscess after drug-eluting bead transarterial chemoembolization for hepatic malignant tumors: Clinical features, pathogenesis, and management.
Wang LJ; Yin L; Liu KC; Lv WF; Lu D
Hepatol Res; 2024 Apr; 54(4):358-367. PubMed ID: 37924506
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC study.
Luo J; Zheng J; Shi C; Fang J; Peng Z; Huang J; Sun J; Zhou G; Li T; Zhu D; Xu H; Hou Q; Ying S; Sun Z; Du H; Xie X; Cao G; Ji W; Han J; Gu W; Guo X; Shao G; Yu Z; Zhou J; Yu W; Zhang X; Li L; Hu H; Hu T; Wu X; Chen Y; Ji J; Hu W
Medicine (Baltimore); 2020 Mar; 99(12):e19276. PubMed ID: 32195932
[TBL] [Abstract][Full Text] [Related]
10. Safety evaluation of combination treatment of drug-eluting bead transarterial chemoembolization and immune checkpoint inhibitors for hepatocellular carcinoma: An increased risk of liver abscess with treatment interval less than one month.
Chiu SH; Lin HH; Feng AC; Lo CH; Hsieh CB; Chen PK; Chang WC
Eur J Radiol; 2024 Jan; 170():111266. PubMed ID: 38185027
[TBL] [Abstract][Full Text] [Related]
11. Treatment of unresectable intrahepatic cholangiocarcinoma using transarterial chemoembolisation with irinotecan-eluting beads: analysis of efficacy and safety.
Liu D; Wang J; Ma Z; Zhang N; Zhao Y; Yang X; Wen Z; Xie H
Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1092-1101. PubMed ID: 35588011
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization Combining Immune Checkpoint Inhibitors in Unresectable Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis.
Yang XG; Sun YY; Li DS; Xu GH; Huang XQ
Front Immunol; 2022; 13():940009. PubMed ID: 35874708
[TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
14. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads.
Guiu B; Deschamps F; Aho S; Munck F; Dromain C; Boige V; Malka D; Leboulleux S; Ducreux M; Schlumberger M; Baudin E; de Baere T
J Hepatol; 2012 Mar; 56(3):609-17. PubMed ID: 22027582
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.
Boehm LM; Jayakrishnan TT; Miura JT; Zacharias AJ; Johnston FM; Turaga KK; Gamblin TC
J Surg Oncol; 2015 Feb; 111(2):213-20. PubMed ID: 25176325
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of efficacy and safety of transarterial chemoembolization with CalliSpheres and conventional transarterial chemoembolization in treating unresectable intrahepatic cholangiocarcinoma patients.
Sun T; Zhang W; Chen L; Ren Y; Liu Y; Zheng C
J Cancer; 2022; 13(4):1282-1288. PubMed ID: 35281867
[No Abstract] [Full Text] [Related]
17. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and treatment of hepatic abscesses with biloma formation after transcatheter arterial chemoembolization.
Zhu M; Li G; Chen Y; Gong G; Guo W
Arab J Gastroenterol; 2022 Feb; 23(1):32-38. PubMed ID: 35153174
[TBL] [Abstract][Full Text] [Related]
19. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
Li J; Wang N; Shi C; Liu Q; Song J; Ye X
J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
[TBL] [Abstract][Full Text] [Related]
20. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
Xing M; Webber G; Prajapati HJ; Chen Z; El-Rayes B; Spivey JR; Pillai AA; Kim HS
J Gastroenterol Hepatol; 2015 Jul; 30(7):1167-74. PubMed ID: 25675849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
